Issue link: https://www.e-digitaleditions.com/i/1532011
RDD® Europe 2025 will be presented May 6-9, 2025 at the Estoril Congress Center in Estoril (Lisbon) Portugal. The event will celebrate 20 years of Respiratory Drug Delivery Europe conferences co- organized by RDD and Aptar Pharma. 10 FEBRUARY 2025 Inhalation RDD ® Europe 2025 will be pre- sented May 6-9, 2025 at the Esto- ril Congress Center in Estoril (Lisbon) Portugal. e event will celebrate 20 years of Respiratory Drug Delivery Europe confer- ences co- organized by RDD and Aptar Pharma. Themed knowledge spaces e conference will feature themed "Knowledge Spaces" that com- bine expert presentations, peer- reviewed conference papers, live "Explore with Experts" discussion sessions, corporate workshop pre- sentations, posters and exhibits. Preliminary topics are: • Bench to Bedside • Pressurized Inhalers • Dry Powder Inhalers • Nasal Delivery • Soft Mist Inhalers and Nebulizers • Inhalation Innovation Additional highlights Delegates will have the opportu- nity to select and attend corpo- rate workshops. e conference will also include posters, a tech- nology exhibition and networking opportunities. To support students, the RDD VCU Peter R. Byron Graduate Student Award will be presented and complimentary registration will be given for up to 20 gradu- ate students with accepted poster abstracts who will present their work in Estoril. For information and registration: https://www.rddonline.com/rdd/ rdd.php?id=25&sid=1 PREVIEWING RDD® EUROPE 2025 ■ Non-PFAS chemistry. ■ Coating integrity results comparable to FEP and PTFE. ■ Environmentally acceptable solvents. ■ Pharmaceutical performance comparable to fluoropolymer- coated cans. ■ A lower carbon footprint than other coatings. Metered dose inhaler can coating experts for nearly 30 years. Our new proprietary MDI coating has: Learn more at biomerics.com/MDICoating